- Home
- BSET vs FHTX Comparison
BSET vs FHTX Comparison
Compare BSET & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BSET | FHTX |
|---|---|---|
| Founded | 1902 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.2M | 111.1M |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BSET | FHTX |
|---|---|---|
| Price | $22.17 | $2.03 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $4.17 |
| AVG Volume (30 Days) | 25.8K | ★ 1.2M |
| Earning Date | 09-30-2026 | 11-04-2026 |
| Dividend Yield | ★ 3.63% | N/A |
| EPS Growth | ★ 163.06 | 25.32 |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $456,855,000.00 | $30,909,000.00 |
| Revenue This Year | $0.85 | N/A |
| Revenue Next Year | $3.42 | $15.98 |
| P/E Ratio | $36.07 | ★ N/A |
| Revenue Growth | 0.96 | ★ 36.75 |
| 52 Week Low | $13.17 | $1.79 |
| 52 Week High | $22.26 | $7.61 |
Technical Indicators
Market Signals| Indicator | BSET | FHTX |
|---|---|---|
| Relative Strength Index (RSI) | 69.97 | 25.12 |
| Support Level | $13.90 | $1.79 |
| Resistance Level | $22.26 | $5.27 |
| Average True Range (ATR) | 0.81 | 0.14 |
| MACD | 0.06 | 0.11 |
| Stochastic Oscillator | 87.10 | 61.43 |
Price Performance
Historical ComparisonAbout BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.